213 related articles for article (PubMed ID: 16288053)
1. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Singh RR; Barnes CJ; Talukder AH; Fuqua SA; Kumar R
Cancer Res; 2005 Nov; 65(22):10594-601. PubMed ID: 16288053
[TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
[TBL] [Abstract][Full Text] [Related]
3. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of a chromatin modifier on ischemia/reperfusion neurons: implication of its regulation of BCL2 transactivation by ERα signaling.
Guo J; Zhang T; Yu J; Li HZ; Zhao C; Qiu J; Zhao B; Zhao J; Li W; Zhao TZ
Cell Tissue Res; 2016 Jun; 364(3):475-488. PubMed ID: 26728277
[TBL] [Abstract][Full Text] [Related]
6. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.
Sum EY; Peng B; Yu X; Chen J; Byrne J; Lindeman GJ; Visvader JE
J Biol Chem; 2002 Mar; 277(10):7849-56. PubMed ID: 11751867
[TBL] [Abstract][Full Text] [Related]
7. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
Mishra SK; Mazumdar A; Vadlamudi RK; Li F; Wang RA; Yu W; Jordan VC; Santen RJ; Kumar R
J Biol Chem; 2003 May; 278(21):19209-19. PubMed ID: 12639951
[TBL] [Abstract][Full Text] [Related]
8. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
10. MTA1 expression correlates significantly with ER-alpha methylation in breast cancer.
Mao XY; Chen H; Wang H; Wei J; Liu C; Zheng HC; Yao F; Jin F
Tumour Biol; 2012 Oct; 33(5):1565-72. PubMed ID: 22644675
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
12. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
Montañez-Wiscovich ME; Seachrist DD; Landis MD; Visvader J; Andersen B; Keri RA
Oncogene; 2009 Oct; 28(41):3608-18. PubMed ID: 19648968
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor.
Kumar R; Balasenthil S; Manavathi B; Rayala SK; Pakala SB
Cancer Res; 2010 Aug; 70(16):6649-58. PubMed ID: 20682799
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells.
Montañez-Wiscovich ME; Shelton MD; Seachrist DD; Lozada KL; Johnson E; Miedler JD; Abdul-Karim FW; Visvader JE; Keri RA
J Pathol; 2010 Nov; 222(3):271-81. PubMed ID: 20814902
[TBL] [Abstract][Full Text] [Related]
15. Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells.
Xiong Z; Ding L; Sun J; Cao J; Lin J; Lu Z; Liu Y; Huang C; Ye Q
IUBMB Life; 2010 Sep; 62(9):669-76. PubMed ID: 20734429
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.
Mazumdar A; Wang RA; Mishra SK; Adam L; Bagheri-Yarmand R; Mandal M; Vadlamudi RK; Kumar R
Nat Cell Biol; 2001 Jan; 3(1):30-7. PubMed ID: 11146623
[TBL] [Abstract][Full Text] [Related]
17. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
18. Two promoters within the human LMO4 gene contribute to its overexpression in breast cancer cells.
Wittlin S; Sum EY; Jonas NK; Lindeman GJ; Visvader JE
Genomics; 2003 Sep; 82(3):280-7. PubMed ID: 12906853
[TBL] [Abstract][Full Text] [Related]
19. MTA1, a transcriptional activator of breast cancer amplified sequence 3.
Gururaj AE; Singh RR; Rayala SK; Holm C; den Hollander P; Zhang H; Balasenthil S; Talukder AH; Landberg G; Kumar R
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6670-5. PubMed ID: 16617102
[TBL] [Abstract][Full Text] [Related]
20. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
